Top

Published in:

01-01-2011 | Article

The dicarboxylate carrier plays a role in mitochondrial malate transport and in the regulation of glucose-stimulated insulin secretion from rat pancreatic beta cells

Authors: P. Huypens, R. Pillai, T. Sheinin, S. Schaefer, M. Huang, M. L. Odegaard, S. M. Ronnebaum, S. D. Wettig, J. W. Joseph

Published in: Diabetologia | Issue 1/2011

Abstract

Aims/hypothesis

We have previously described a strong correlation between pyruvate cycling and insulin secretion. We have also demonstrated a particularly important role for a pyruvate–isocitrate cycling pathway involving the mitochondrial citrate/isocitrate carrier (CIC) and cytosolic NADP-dependent isocitrate dehydrogenase. CIC requires cytosolic malate as a counter-substrate during citrate and isocitrate export. Thus, considering that the mitochondrial dicarboxylate carrier (DIC) provides an important source of cytosolic malate, we investigated the potential role of DIC in control of glucose-stimulated insulin secretion (GSIS).

Methods

We used pharmacological and small interfering RNA (siRNA) tools to assess the role of DIC in insulin release in clonal insulin-secreting 832/13 cells and isolated rat islets.

Results

Butylmalonate, an inhibitor of malate transport, reduced cytosolic malate and citrate levels, and inhibited GSIS in a dose-dependent manner in 832/13 cells. Suppression of DIC expression resulted in inhibition of GSIS by 5% to 69%, the extent of inhibition of insulin secretion being proportional to the level of Dic (also known as Slc25a10) gene knockdown. The most effective siRNA duplex against Dic did not affect glucose utilisation, glucose oxidation or ATP/ADP ratio, but did suppress glucose-induced increments of the NADPH/NADP⁺ ratio. Confirmation of our results in primary cultures of isolated rat islets showed that butylmalonate and an adenovirus expressing an siRNA against Dic-inhibited GSIS.

Conclusions/interpretation

Malate transport by DIC may play an important role in GSIS, possibly by providing cytosolic malate as a counter-substrate for citrate and/or isocitrate export by CIC. These studies also suggest that malate transport by DIC is (1) a critical component of NADPH production mediated by pyruvate-cycling and (2) regulates GSIS.

Available only for authorised users

Ashcroft FM, Rorsman P (1989) Electrophysiology of the pancreatic beta-cell. Prog Biophys Mol Biol 54:87–143CrossRefPubMed

Henquin JC (2004) Pathways in beta-cell stimulus-secretion coupling as targets for therapeutic insulin secretagogues. Diabetes 53(Suppl 3):S48–S58CrossRefPubMed

Gembal M, Gilon P, Henquin JC (1992) Evidence that glucose can control insulin release independently from its action on ATP-sensitive K⁺ channels in mouse B cells. J Clin Invest 89:1288–1295CrossRefPubMed

Henquin JC, Ravier MA, Nenquin M, Jonas JC, Gilon P (2003) Hierarchy of the beta-cell signals controlling insulin secretion. Eur J Clin Invest 33:742–750CrossRefPubMed

Nenquin M, Szollosi A, Guilar-Bryan L, Bryan J, Henquin JC (2004) Both triggering and amplifying pathways contribute to fuel-induced insulin secretion in the absence of sulfonylurea receptor-1 in pancreatic beta-cells. J Biol Chem 279:32316–32324CrossRefPubMed

Sato Y, Aizawa T, Komatsu M, Okada N, Yamada T (1992) Dual functional role of membrane depolarization/Ca2⁺ influx in rat pancreatic B-cell. Diabetes 41:438–443CrossRefPubMed

Szollosi A, Nenquin M, Henquin JC (2010) Pharmacological stimulation and inhibition of insulin secretion in mouse islets lacking ATP-sensitive K(+) channels. Br J Pharmacol 159:669–677CrossRefPubMed

Ravier MA, Nenquin M, Miki T, Seino S, Henquin JC (2009) Glucose controls cytosolic Ca²⁺ and insulin secretion in mouse islets lacking adenosine triphosphate-sensitive K⁺ channels owing to a knockout of the pore-forming subunit Kir6.2. Endocrinology 150:33–45CrossRefPubMed

Quoix N, Cheng-Xue R, Mattart L et al (2009) Glucose and pharmacological modulators of ATP-sensitive K⁺ channels control [Ca²⁺]c by different mechanisms in isolated mouse alpha-cells. Diabetes 58:412–421CrossRefPubMed

10.

Henquin JC, Nenquin M, Ravier MA, Szollosi A (2009) Shortcomings of current models of glucose-induced insulin secretion. Diabetes Obes Metab 11(Suppl 4):168–179CrossRefPubMed

11.

Henquin JC (2009) Regulation of insulin secretion: a matter of phase control and amplitude modulation. Diabetologia 52:739–751CrossRefPubMed

12.

Jensen MV, Joseph JW, Ronnebaum SM, Burgess SC, Sherry AD, Newgard CB (2008) Metabolic cycling in control of glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab 295:E1287–E1297CrossRefPubMed

13.

Hasan NM, Longacre MJ, Stoker SW et al (2008) Impaired anaplerosis and insulin secretion in insulinoma cells caused by small interfering RNA-mediated suppression of pyruvate carboxylase. J Biol Chem 283:28048–28059CrossRefPubMed

14.

MacDonald MJ, Stoker SW, Hasan NM (2008) Anaplerosis from glucose, alpha-ketoisocaproate, and pyruvate in pancreatic islets, INS-1 cells and liver mitochondria. Mol Cell Biochem 313:195–202CrossRefPubMed

15.

Lu D, Mulder H, Zhao P et al (2002) ¹³C NMR isotopomer analysis reveals a connection between pyruvate cycling and glucose-stimulated insulin secretion (GSIS). Proc Natl Acad Sci USA 99:2708–2713CrossRefPubMed

16.

Maechler P, Antinozzi PA, Wollheim CB (2000) Modulation of glutamate generation in mitochondria affects hormone secretion in INS-1E beta cells. IUBMB Life 50:27–31CrossRefPubMed

17.

Joseph JW, Jensen MV, Ilkayeva O et al (2006) The mitochondrial citrate/isocitrate carrier plays a regulatory role in glucose-stimulated insulin secretion. J Biol Chem 281:35624–35632CrossRefPubMed

18.

Agascioglu E, Giroix MH, Malaisse WJ, Sener A (2006) Adenine nucleotide pattern in rat pancreatic islets exposed to nutrient secretagogues. Endocr 29:325–329CrossRef

19.

Jensen MV, Joseph JW, Ilkayeva O et al (2006) Compensatory responses to pyruvate carboxylase suppression in islet beta-cells. Preservation of glucose-stimulated insulin secretion. J Biol Chem 281:22342–22351CrossRefPubMed

20.

Szollosi A, Nenquin M, Henquin JC (2007) Overnight culture unmasks glucose-induced insulin secretion in mouse islets lacking ATP-sensitive K⁺ channels by improving the triggering Ca²⁺ signal. J Biol Chem 282:14768–14776CrossRefPubMed

21.

Szollosi A, Nenquin M, Guilar-Bryan L, Bryan J, Henquin JC (2007) Glucose stimulates Ca²⁺ influx and insulin secretion in 2-week-old beta-cells lacking ATP-sensitive K⁺ channels. J Biol Chem 282:1747–1756CrossRefPubMed

22.

Palmieri F (2004) The mitochondrial transporter family (SLC25): physiological and pathological implications. Pflügers Arch Eur J Physiol 447:689–709CrossRef

23.

Ronnebaum SM, Ilkayeva O, Burgess SC et al (2006) A pyruvate cycling pathway involving cytosolic NADP-dependent isocitrate dehydrogenase regulates glucose-stimulated insulin secretion. J Biol Chem 281:30593–30602CrossRefPubMed

24.

Cline GW, Lepine RL, Papas KK, Kibbey RG, Shulman GI (2004) ¹³C NMR isotopomer analysis of anaplerotic pathways in INS-1 cells. J Biol Chem 279:44370–44375CrossRefPubMed

25.

Joseph JW, Odegaard ML, Ronnebaum SM et al (2007) Normal flux through ATP-citrate lyase or fatty acid synthase is not required for glucose-stimulated insulin secretion. J Biol Chem 282:31592–31600CrossRefPubMed

26.

Brown LJ, Longacre MJ, Hasan NM, Kendrick MA, Stoker SW, MacDonald MJ (2009) Chronic reduction of the cytosolic or NAD(P)-mitochondrial malic enzyme does not affect insulin secretion in a rat insulinoma cell line. J Biol Chem 284:35359–35367CrossRefPubMed

27.

Ronnebaum SM, Jensen MV, Hohmeier HE et al (2008) Silencing of cytosolic or mitochondrial isoforms of malic enzyme has no effect on glucose-stimulated insulin secretion from rodent islets. J Biol Chem 283:28909–28917CrossRefPubMed

28.

Xu J, Han J, Long YS et al (2008) Malic enzyme is present in mouse islets and modulates insulin secretion. Diabetologia 51:2281–2289CrossRefPubMed

29.

Pongratz RL, Kibbey RG, Shulman GI, Cline GW (2007) Cytosolic and mitochondrial malic enzyme isoforms differentially control insulin secretion. J Biol Chem 282:200–207CrossRefPubMed

30.

Guay C, Madiraju SR, Aumais A, Joly E, Prentki M (2007) A role for ATP-citrate lyase, malic enzyme, and pyruvate/citrate cycling in glucose-induced insulin secretion. J Biol Chem 282:35657–35665CrossRefPubMed

31.

Hohmeier HE, Mulder H, Chen G, Henkel-Rieger R, Prentki M, Newgard CB (2000) Isolation of INS-1-derived cell lines with robust ATP-sensitive K⁺ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes 49:424–430CrossRefPubMed

32.

Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB (1992) Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130:167–178CrossRefPubMed

33.

Koshkin V, Bikopoulos G, Chan CB, Wheeler MB (2004) The characterization of mitochondrial permeability transition in clonal pancreatic beta-cells. Multiple modes and regulation. J Biol Chem 279:41368–41376CrossRefPubMed

34.

Civelek VN, Deeney JT, Shalosky NJ et al (1996) Regulation of pancreatic beta-cell mitochondrial metabolism: influence of Ca²⁺, substrate and ADP. Biochem J 318:615–621PubMed

35.

MacDonald MJ (1995) Feasibility of a mitochondrial pyruvate malate shuttle in pancreatic islets. Further implication of cytosolic NADPH in insulin secretion. J Biol Chem 270:20051–20058PubMed

36.

MacDonald MJ (1982) Evidence for the malate aspartate shuttle in pancreatic islets. Arch Biochem Biophys 213:643–649CrossRefPubMed

37.

Joseph JW, Koshkin V, Saleh MC et al (2004) Free fatty acid-induced beta-cell defects are dependent on uncoupling protein 2 expression. J Biol Chem 279:51049–51056CrossRefPubMed

38.

Ronnebaum SM, Joseph JW, Ilkayeva O et al (2008) Chronic suppression of acetyl-CoA carboxylase 1 in beta-cells impairs insulin secretion via inhibition of glucose rather than lipid metabolism. J Biol Chem 283:14248–14256CrossRefPubMed

39.

MacDonald MJ (1993) Estimates of glycolysis, pyruvate (de)carboxylation, pentose phosphate pathway, and methyl succinate metabolism in incapacitated pancreatic islets. Arch Biochem Biophys 305:205–214CrossRefPubMed

40.

Khan A, Ling ZC, Landau BR (1996) Quantifying the carboxylation of pyruvate in pancreatic islets. J Biol Chem 271:2539–2542CrossRefPubMed

41.

Schuit F, De Vos A, Farfari S et al (1997) Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in beta cells. J Biol Chem 272:18572–18579CrossRefPubMed

42.

MacDonald PE, Joseph JW, Rorsman P (2005) Glucose-sensing mechanisms in pancreatic beta-cells. Philos Trans R Soc Lond B Biol Sci 360:2211–2225CrossRefPubMed

43.

MacDonald MJ, Fahien LA, Brown LJ, Hasan NM, Buss JD, Kendrick MA (2005) Perspective: emerging evidence for signaling roles of mitochondrial anaplerotic products in insulin secretion. Am J Physiol Endocrinol Metab 288:E1–E15CrossRefPubMed

44.

Deeney JT, Prentki M, Corkey BE (2000) Metabolic control of beta-cell function. Semin Cell Dev Biol 11:267–275CrossRefPubMed

45.

Corkey BE, Glennon MC, Chen KS, Deeney JT, Matschinsky FM, Prentki M (1989) A role for malonyl-CoA in glucose-stimulated insulin secretion from clonal pancreatic beta-cells. J Biol Chem 264:21608–21612PubMed

46.

Prentki M, Vischer S, Glennon MC, Regazzi R, Deeney JT, Corkey BE (1992) Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion. J Biol Chem 267:5802–5810PubMed

47.

McGarry JD (2002) Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51:7–18CrossRefPubMed

48.

Prentki M, Murthy M Sr (2008) Glycerolipid metabolism and signaling in health and disease. Endocr Rev 29:647–676CrossRefPubMed

49.

Chakravarthy MV, Zhu Y, Lopez M et al (2007) Brain fatty acid synthase activates PPARalpha to maintain energy homeostasis. J Clin Invest 117:2539–2552CrossRefPubMed

50.

MacDonald MJ, Hasan NM, Longacre MJ (2008) Studies with leucine, beta-hydroxybutyrate and ATP citrate lyase-deficient beta cells support the acetoacetate pathway of insulin secretion. Biochim Biophys Acta 1780:966–972PubMed

51.

MacDonald MJ, Smith AD III, Hasan NM, Sabat G, Fahien LA (2007) Feasibility of pathways for transfer of acyl groups from mitochondria to the cytosol to form short chain acyl-CoAs in the pancreatic beta cell. J Biol Chem 282:30596–30606CrossRefPubMed

52.

Ivarsson R, Quintens R, Dejonghe S et al (2005) Redox control of exocytosis: regulatory role of NADPH, thioredoxin, and glutaredoxin. Diabetes 54:2132–2142CrossRefPubMed

53.

MacDonald PE, Salapatek AM, Wheeler MB (2003) Temperature and redox state dependence of native Kv2.1 currents in rat pancreatic beta-cells. J. J Physiol 546:647–653CrossRefPubMed

54.

Rabaglia ME, Gray-Keller MP, Frey BL, Shortreed MR, Smith LM, Attie AD (2005) Alpha-ketoisocaproate-induced hypersecretion of insulin by islets from diabetes-susceptible mice. Am J Physiol Endocrinol Metab 289:E218–E224CrossRefPubMed

55.

Odegaard ML, Joseph JW, Jensen MV et al (2010) The mitochondrial 2-oxoglutarate carrier is part of a metabolic pathway that mediates glucose- and glutamine-stimulated insulin secretion. J Biol Chem 285:16530–16537CrossRefPubMed

56.

Ozer A, Bruick RK (2007) Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one? Nat Chem Biol 3:144–153CrossRefPubMed

57.

Fallon MJ, MacDonald MJ (2008) Beta-cell alpha-ketoglutarate hydroxylases may acutely participate in insulin secretion. Metabolism 57:1148–1154CrossRefPubMed

Title: The dicarboxylate carrier plays a role in mitochondrial malate transport and in the regulation of glucose-stimulated insulin secretion from rat pancreatic beta cells
Authors: P. Huypens
R. Pillai
T. Sheinin
S. Schaefer
M. Huang
M. L. Odegaard
S. M. Ronnebaum
S. D. Wettig
J. W. Joseph
Publication date: 01-01-2011
Publisher: Springer-Verlag
Published in: Diabetologia / Issue 1/2011
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-010-1923-5

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Please log in to get access to this content

Other articles of this Issue 1/2011

An intrinsic circadian clock of the pancreas is required for normal insulin release and glucose homeostasis in mice

Dissociation between fatty liver and insulin resistance: the role of adipose triacylglycerol lipase

AMP-activated protein kinase regulates glucagon secretion from mouse pancreatic alpha cells

Impaired insulin-induced site-specific phosphorylation of TBC1 domain family, member 4 (TBC1D4) in skeletal muscle of type 2 diabetes patients is restored by endurance exercise-training

Non-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus

Immunological and C-peptide studies of patients with diabetes in northern Ethiopia: existence of an unusual subgroup possibly related to malnutrition

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials